Legislative Session Wrap: California Chamber of Commerce Report

On September 30, Governor Gavin Newsom concluded review and action on more than 1,200 bills sent to his desk as part of the 2024 regular legislative session. This year represented many major legislative wins for the California Chamber of Commerce working on behalf of California employers.

Read More

Medicare Coverage Of Weight Loss Drugs Would Cost $35B: CBO

In its estimates released Tuesday, CBO said 12.5 million Medicare beneficiaries would qualify for the medications beginning in 2026, and 2 percent would be expected to use the drugs in the first year.

Read More

Walgreens Plans To Close 1,200 Stores By 2027 As Part Of Ongoing Turnaround Strategy

Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore chain’s ongoing turnaround strategy amid a rocky fiscal 2024. The company will close 500 stores next year as it works to improve its cash flow. The closure ...

Read More

Changes In Store For Medicare Advantage As Open Enrollment Starts

Attention, Medicare Advantage enrollees: It’s a good idea to review your plans during open enrollment, which begins Tuesday, so you don’t get caught by surprise next year. Although the swiftly growing market remains stable overall, insurers are making a flurry of changes that could leave some senior citizens hunting for new policies, paying more out ...

Read More

Supreme Court Takes Up PBM Case: Does ERISA Preempt States’ Efforts To Regulate Drug Prices?

The U.S. Supreme Court plans to look at states’ ability to regulate pharmacy benefit managers this term. Glen Mulready, Oklahoma’s insurance commissioner, is trying to overturn an appeals court ruling that found that the Employee Retirement Income Security Act of 1974 benefits rule uniformity provisions preempts state efforts to regulate PBMs when the PBMs are serving ...

Read More

CMS Rolls Out Proposed Generic Drug List To Ease Cost-Sharing Burden

The Centers for Medicare & Medicaid Services (CMS) released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. Designed to limit out-of-pocket costs, the plan caps a generic drug’s monthly price at $2. Drugs included in the list help tackle conditions like high ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square